These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23393115)

  • 1. GSK backs campaign for disclosure of trial data.
    Kmietowicz Z
    BMJ; 2013 Feb; 346():f819. PubMed ID: 23393115
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-company data vaults to be opened.
    Cressey D
    Nature; 2013 Mar; 495(7442):419-20. PubMed ID: 23538802
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trial data as a public good.
    Rodwin MA; Abramson JD
    JAMA; 2012 Sep; 308(9):871-2. PubMed ID: 22948695
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials. Facing criticism, industry offers to share data.
    Couzin J
    Science; 2005 Jan; 307(5707):189. PubMed ID: 15653471
    [No Abstract]   [Full Text] [Related]  

  • 5. Industry anger over stringent trial disclosure requirements.
    Wadman M
    Nat Rev Drug Discov; 2006 Jul; 5(7):527-8. PubMed ID: 16883642
    [No Abstract]   [Full Text] [Related]  

  • 6. Making available information from studies sponsored by the pharmaceutical industry: some current practices.
    O'Kelly M; Julious SA; Pyke S; Day S; Todd S; Seldrup J; Matcham J
    Pharm Stat; 2011; 10(1):60-9. PubMed ID: 21275036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.
    Kesselheim AS; Mello MM
    Health Aff (Millwood); 2007; 26(2):483-91. PubMed ID: 17339677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials registries: towards improved access to therapeutic data.
    Prescrire Int; 2008 Dec; 17(98):256-9. PubMed ID: 19425275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why industry should register and disclose results of clinical studies--perspective of a recovering academic.
    Berlin JA
    BMJ; 2005 Apr; 330(7497):959. PubMed ID: 15845981
    [No Abstract]   [Full Text] [Related]  

  • 10. Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment.
    Baronikova S; Purvis J; Southam E; Beeso J; Panayi A; Winchester C
    BMJ Evid Based Med; 2019 Oct; 24(5):177-184. PubMed ID: 30898790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expose your clinical thinking.
    Nat Biotechnol; 2004 Aug; 22(8):927. PubMed ID: 15286628
    [No Abstract]   [Full Text] [Related]  

  • 12. Registering clinical trials in India.
    Bhatt A; Sewlikar S
    Natl Med J India; 2006; 19(1):1-3. PubMed ID: 16570676
    [No Abstract]   [Full Text] [Related]  

  • 13. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
    Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
    Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making all clinical trials available for review: any impact on clinical decisions?
    Smith GH
    J Am Pharm Assoc (2003); 2005; 45(1):7-8. PubMed ID: 15730109
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug giants fail to name compounds in trial database.
    Wadman M
    Nature; 2005 Jun; 435(7042):548. PubMed ID: 15931185
    [No Abstract]   [Full Text] [Related]  

  • 16. GSK backs BMJ's new policy to publish only studies with full access to data.
    Kmietowicz Z
    BMJ; 2012 Nov; 345():e7404. PubMed ID: 23118332
    [No Abstract]   [Full Text] [Related]  

  • 17. Calls for full disclosure of clinical trials.
    Frantz S
    Nat Rev Drug Discov; 2004 Aug; 3(8):635-6. PubMed ID: 15317144
    [No Abstract]   [Full Text] [Related]  

  • 18. NICE joins campaign for full disclosure of clinical trial data.
    Limb M
    BMJ; 2013 Feb; 346():f1269. PubMed ID: 23440345
    [No Abstract]   [Full Text] [Related]  

  • 19. European drug agency works to improve transparency, but skepticism remains.
    Hampton T
    JAMA; 2012 Sep; 308(9):850-1. PubMed ID: 22948681
    [No Abstract]   [Full Text] [Related]  

  • 20. Trials and tribulations: new pressure on drug companies to reveal all about their clinical tests.
    Economist; 2004 Jun; 371(8380):62-3. PubMed ID: 15457617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.